Similar articles

• Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias.

  Belge G, Meyer A, Klemke M, Burchardt K, Stern C, Wosniok W, Loeschke S, Bullerdiek J. Belge G, et al. Genes Chromosomes Cancer. 2008 Jan;47(1):56-63. doi: 10.1002/gcc.20505. Genes Chromosomes Cancer. 2008. PMID: 17943974
• Combined quantitation of HMGA2 mRNA, microRNAs, and mitochondrial-DNA content enables the identification and typing of thyroid tumors in fine-needle aspiration smears.

  Titov SE, Ivanov MK, Demenkov PS, Katanyan GA, Kozorezova ES, Malek AV, Veryaskina YA, Zhimulev IF. Titov SE, et al. BMC Cancer. 2019 Oct 28;19(1):1010. doi: 10.1186/s12885-019-6154-7. BMC Cancer. 2019. PMID: 31660895 Free PMC article.
• High Diagnostic Accuracy Based on CLDN10, HMGA2, and LAMB3 Transcripts in Papillary Thyroid Carcinoma.

  Barros-Filho MC, Marchi FA, Pinto CA, Rogatto SR, Kowalski LP. Barros-Filho MC, et al. J Clin Endocrinol Metab. 2015 Jun;100(6):E890-9. doi: 10.1210/jc.2014-4053. Epub 2015 Apr 13. J Clin Endocrinol Metab. 2015. PMID: 25867809
• My approach to oncocytic tumours of the thyroid.

  Asa SL. Asa SL. J Clin Pathol. 2004 Mar;57(3):225-32. doi: 10.1136/jcp.2003.008474. J Clin Pathol. 2004. PMID: 14990587 Free PMC article. Review.
• [Biological markers in thyroid tumors].

  Matsuo SE, Martins L, Leoni SG, Hajjar D, Ricarte-Filho JC, Ebina KN, Kimura ET. Matsuo SE, et al. Arq Bras Endocrinol Metabol. 2004 Feb;48(1):114-25. doi: 10.1590/s0004-27302004000100013. Epub 2004 Jun 1. Arq Bras Endocrinol Metabol. 2004. PMID: 15611824 Review. Portuguese.